Long-term outcome after coronary stenting

Current Controlled Trials in Cardiovascular Medicine

Volumn 1, Issue 1, 2000, Pages 48-54

  Kastrati, A ^a   Hall, D ^a   Schomig A ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Coronary artery disease; Long term outcome; Restenosis; Stents; Thrombosis

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; HEPARIN; PLACEBO; TICLOPIDINE;

ANGIOCARDIOGRAPHY; ARTERY INTIMA; ARTERY OCCLUSION; BRACHYTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; CORONARY STENT; DIAGNOSTIC IMAGING; HUMAN; RANDOMIZED CONTROLLED TRIAL; REMISSION; RESTENOSIS; REVIEW; STIMULUS; TIME; TREATMENT OUTCOME; ULTRASOUND;

EID: 0034466926     PISSN: 14686708     EISSN: None     Source Type: Journal    
DOI: 10.1186/CVM-1-1-048     Document Type: Review

References (51)

1. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty
2. Long lesions, long stents and the long process of stent optimization
3. Angiographic follow-up after placement of a self-expanding coronary-artery stent
4. Four-year experience with Palmaz-Schatz stenting in coronary angioplasty complicated by dissection with threatened or present vessel closure
5. Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary Palmaz-Schatz stenting
6. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance
7. Platelet activation and coronary stent implantation: Effect of antithrombotic therapy
8. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents
9. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
10. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting
11. Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial
12. Influence of balloon pressure during stent placement in native coronary arteries on early and late angiographic and clinical outcome: A randomized evaluation of high-pressure inflation
13. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease
14. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
15. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts
16. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease
17. Coronary angioplasty with or without stent implantation for acute myocardial infarction
18. A randomized trial comparing primary stenting plus glycoprotein IIb/IIIa blockade with tissue plasminogen activator for myocardial salvage in acute myocardial infarction
19. Pathobiologic responses to stenting
20. Pathology of acute and chronic coronary stenting in humans
21. Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses
22. Endovascular stent design dictates experimental restenosis and thrombosis
23. Coronary intimal proliferation after balloon injury and stenting in swine: An animal model of restenosis
24. Histopathologic comparison of human coronary in-stent and post-balloon angioplasty restenotic tissue
25. Apoptosis after stent implantation compared with balloon angioplasty in rabbits. Role of macrophages
26. Acute and chronic tissue response to coronary stent implantation: Pathologic findings in human specimen
27. Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement
28. Interlesion dependence of the risk for restenosis in patients with coronary stent placement in multiple lesions
29. Genetic risk factors and restenosis after percutaneous coronary interventions
30. Intravascular ultrasound to discern device-specific efects and mechanisms of restenosis
31. Serial angiographic follow-up after Palmaz-Schatz stent implantation: Comparison with conventional balloon angioplasty
32. Time course of restenosis during the first year after emergency coronary stenting
33. Three-year follow-up after implantation of metallic coronary-artery stents
34. Remodeling of in-stent neointima, which became thinner and transparent over 3 years: Serial angiographic and angioscopic follow-up
35. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)
36. Impact of routine angiographic follow-up after angioplasty
37. Continued benefit of coronary stenting versus balloon angioplasty: One-year clinical follow-up of Benestent trial
38. One-year follow-up of the Stent Restenosis (STRESS 1) Study
39. Meeting highlights. Highlights of the 21st Congress of the European Society of Cardiology
40. Influence of stent design on one-year outcome after coronary stent placement: A randomized comparison of 5 stent types in 1147 unselected patients
41. Increased risk of restenosis after placement of gold-coated stents. Results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease
42. Complications and follow-up after intracoronary stenting: Critical analysis of a 6-year single-center experience
43. Three-year clinical follow-up after Palmaz-Schatz stenting
44. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: Paucity of late clinical stent-related problems
45. Randomized comparison of coronary stent implantation and balloon angioplasty in the treatment of de novo coronary artery lesions (START): A four-year follow-up
46. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of BENESTENT-I trial
47. Long-term outcome after coronary stent implantation: A 10 year single centre experience of 1000 patients
48. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome
49. Three-year clinical and angiographic follow-up after intracoronary radiation: Results of a randomized clinical trial
50. Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis